SCHEMBL5002178

SCHEMBL5002178

NC(=O)CC1(CS)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29990577 0.77
SCHEMBL625309 0.77
SCHEMBL8787170 0.75
SCHEMBL5713265 0.75
SCHEMBL30487348 0.75
SCHEMBL990885 0.75 CYP1A2 (0.45)
SCHEMBL6124890 0.75
Cesium SCHEMBL625472 0.75 CYP1A2 (0.45)
SCHEMBL626489 0.75 CYP1A2 (0.45)
SCHEMBL11340444 0.74 CYP1A2 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1948611-B1 Process for the preparation of a leukotriene antagonist and intermediates thereof ESTEVE QUIMICA SA (ES) 2012-05-23 EP disclosed
US-20080306270-A1 Process for the Preparation of a Leukotriene Antagonist and Intermediates Thereof Esteve Química, S.A. (ES) 2008-12-11 US disclosed
EP-1948611-A2 PROCESS FOR THE PREPARATION OF A LEUKOTRIENE ANTAGONIST AND INTERMEDIATES THEREOF ESTEVE QUIMICA, S.A. (ES) 2008-07-30 EP disclosed
WO-2007051828-A2 PROCESS FOR THE PREPARATION OF A LEUKOTRIENE ANTAGONIST AND INTERMEDIATES THEREOF ESTEVE QUÍMICA, S. A. (ES) 2007-05-10 WO disclosed
US-7189853-B2 Process for the preparation of [R-(E)-1-[[[1-[3-[2-[7-chloro-2-quinolinyl]ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid (Montelukast) and its pharmaceutically acceptable salts DR. REDDY'S LABORATORIES LIMITED (IN) 2007-03-13 US disclosed
US-20050234241-A1 Process for the preparation of [R-(E)-1-[[[1-[3-[2-[7-chloro-2-quinolinyl]ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid (montelukast) and its pharmaceutically acceptable salts U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT 2005-10-20 US disclosed
US-6320052-B1 CRYSTALLINE PRECURSORS OF 1-(((1(R)-(3-(2-(7-CHLORO-2-QUINO LYNYL)ETHENYL)PHENYL)-3-(2-HYDROXY-1-METHYL-ETHYL)PHENYL) PROPYL)THIO)METHYL)CYCLOPROPYLACETIC ACID MERCK & CO., INC. 2001-11-20 US disclosed
EP-0737186-B1 PROCESS FOR THE PREPARATION OF LEUKOTRIENE ANTAGONISTS MERCK & CO INC (US) 1998-08-19 EP disclosed
EP-0641775-B1 Process for the production of gamma-mercapto carbonic acid derivatives LONZA AG (CH) 1998-04-15 EP disclosed
EP-0805808-A1 PROCESS FOR THE PREPARATION OF 1-(THIOMETHYL)-CYCLOPROPANEACETIC ACID Merck & Co., Inc. (US) 1997-11-12 EP disclosed
US-5614632-A Process for the preparation of leukotriene anatgonists MERCK & CO., INC. (US) 1997-03-25 US disclosed
EP-0737186-A1 PROCESS FOR THE PREPARATION OF LEUKOTRIENE ANTAGONISTS MERCK & CO. INC. (US) 1996-10-16 EP disclosed
WO-1996022987-A1 PROCESS FOR THE PREPARATION OF 1-(THIOMETHYL)-CYCLOPROPANEACETIC ACID MERCK & CO., INC. (US) 1996-08-01 WO disclosed
US-5534651-A REACTING A BUTYROLACTONE WITH THIOCARBOXYLATE TO FORM THIOLACTONE; DECYCLIZATION WITH NUCLEOPHILE LONZA LTD. (CH) 1996-07-09 US disclosed
US-5523477-A REACTING 1,1-CYCLOPROPANEDIMETHANOL WITH DIALKYL SULFITE IN PRESENCE OF ACID OR BASE TO FORM CYCLIC SULFITE, REMOVING ALCOHOL REACTION BY-PRODUCT MERCK & CO., INC. (US) 1996-06-04 US disclosed
WO-1995018107-A1 PROCESS FOR THE PREPARATION OF LEUKOTRIENE ANTAGONISTS MERCK & CO., INC. (US) 1995-07-06 WO disclosed